HELP
Income statement / Annual
Last year (2025), Helus Pharma Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Helus Pharma Inc.'s net income was -$113.14 M.
See Helus Pharma Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
03/31/2025 |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
07/31/2019 |
07/31/2018 |
07/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$864.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$472.27 K
|
$424.74 K
|
$251.02 K
|
$167.76 K
|
$1.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$472.27 K
|
-$424.74 K
|
-$251.02 K
|
-$167.76 K
|
-$311.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
-0.36
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$54.91 M
|
$32.36 M
|
$25.49 M
|
$17.59 M
|
$3.30 M
|
$321.60 K
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$84.95 M
|
$27.90 M
|
$25.15 M
|
$44.79 M
|
$25.87 M
|
$1.36 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$3.29 M
|
$4.69 M
|
$881.00 K
|
$1.47 M
|
$1.56 M
|
$117.60 K
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$88.24 M
|
$46.47 M
|
$26.03 M
|
$46.25 M
|
$27.42 M
|
$1.63 M
|
$80.52 K
|
$189.95 K
|
$127.22 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$9.60 K
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$143.15 M
|
$78.84 M
|
$51.52 M
|
$63.84 M
|
$30.72 M
|
$1.94 M
|
$80.52 K
|
$189.95 K
|
$127.22 K
|
| Cost And Expenses |
$143.15 M
|
$78.84 M
|
$51.52 M
|
$63.84 M
|
$31.90 M
|
$1.94 M
|
$80.52 K
|
$189.95 K
|
$127.22 K
|
| Interest Income |
$8.29 M
|
$619.00 K
|
$603.00 K
|
$241.00 K
|
$60.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$10.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$475.00 K
|
$424.00 K
|
$251.00 K
|
$168.00 K
|
$49.00 K
|
$1.95 M
|
$0.00
|
$0.00
|
$0.00
|
| EBITDA |
-$142.67 M |
-$78.41 M |
-$51.27 M |
-$63.67 M |
-$30.99 M |
$9.60 K |
-$80.91 K |
-$220.81 K |
-$127.00 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
-35.86
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
-35.92
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$30.01 M
|
$756.00 K
|
$4.03 M
|
-$3.79 M
|
-$1.19 M
|
$9.60 K
|
-$20.00 K
|
-$30.86 K
|
$4.00
|
| Income Before Tax |
-$113.14 M
|
-$78.08 M
|
-$47.49 M
|
-$67.63 M
|
-$32.22 M
|
-$1.94 M
|
-$101.00 K
|
-$220.81 K
|
-$127.00 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
-37.29
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$113.14 M
|
-$78.08 M
|
-$47.49 M
|
-$67.63 M
|
-$32.22 M
|
-$1.94 M
|
-$101.00 K
|
-$220.81 K
|
-$127.00 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
-37.29
|
0
|
0
|
0
|
0
|
| EPS |
-5.59 |
-3.91 |
-9.73 |
-15.36 |
-12.24 |
-1.48 |
-0.28 |
-0.69 |
-0.35 |
| EPS Diluted |
-5.59 |
-9.41 |
-9.74 |
-15.36 |
-12.24 |
-1.82 |
-0.28 |
-0.69 |
-0.35 |
| Weighted Average Shares Out |
$20.22 M
|
$20.00 M
|
$4.88 M
|
$4.40 M
|
$2.63 M
|
$1.07 M
|
$365.43 K
|
$320.15 K
|
$360.53 K
|
| Weighted Average Shares Out Diluted |
$20.22 M
|
$20.00 M
|
$4.88 M
|
$4.40 M
|
$2.63 M
|
$1.32 M
|
$365.43 K
|
$320.15 K
|
$360.53 K
|
| Link |
|
|
|
|
|
|
|
|
|
